Medherant secures funds of £1.5m for transdermal patch
Coventry, UK-based University of Warwick spin-out Medherant has secured funding of £1.5 million to fuel further development of its novel drug patch delivery technology.
Read More
Tag: Mercia
- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
- ALK’s EURneffy receives positive CHMP opinion for emergency anaphylaxis treatment in children
- CERo reports encouraging early data from phase 1 trial of CER‑1236
